STERIALS

The company develops, manufactures and sells prescription drugs and vaccines, as well as engages in the consumer healthcare business. Utilizing a broad range of technologies, including mRNA, and its drug discovery platform, the company is conducting clinical trials of vaccine candidates for influenza, respiratory syncytial virus, and other diseases, as well as developing treatments for immune disorders, inflammation, oncology, rare diseases, and rare blood disorders.